207 related articles for article (PubMed ID: 27487100)
1. Are we ready for precision medicine in acute myeloid leukemia?
Roboz GJ
Clin Adv Hematol Oncol; 2016 Aug; 14(8):582-4. PubMed ID: 27487100
[No Abstract] [Full Text] [Related]
2. Toward Individualized Therapy in Acute Myeloid Leukemia: A Contemporary Review.
Kadia TM; Ravandi F; Cortes J; Kantarjian H
JAMA Oncol; 2015 Sep; 1(6):820-8. PubMed ID: 26181162
[TBL] [Abstract][Full Text] [Related]
3. How I treat the older patient with acute myeloid leukemia.
Ossenkoppele G; Löwenberg B
Blood; 2015 Jan; 125(5):767-74. PubMed ID: 25515963
[TBL] [Abstract][Full Text] [Related]
4. How Precision Medicine Is Changing Acute Myeloid Leukemia Therapy.
Heuser M; Mina A; Stein EM; Altman JK
Am Soc Clin Oncol Educ Book; 2019 Jan; 39():411-420. PubMed ID: 31099617
[TBL] [Abstract][Full Text] [Related]
5. [Acute myeloid leukemia. Genetic diagnostics and molecular therapy].
Schlenk RF; Döhner K; Döhner H
Internist (Berl); 2013 Feb; 54(2):171-8. PubMed ID: 23358744
[TBL] [Abstract][Full Text] [Related]
6. Precision therapy for acute myeloid leukemia.
Yang X; Wang J
J Hematol Oncol; 2018 Jan; 11(1):3. PubMed ID: 29301553
[TBL] [Abstract][Full Text] [Related]
7. Precision medicine in acute myeloid leukemia: where are we now and what does the future hold?
Megías-Vericat JE; Martínez-Cuadrón D; Solana-Altabella A; Montesinos P
Expert Rev Hematol; 2020 Oct; 13(10):1057-1065. PubMed ID: 32869672
[TBL] [Abstract][Full Text] [Related]
8. Unfavorable-risk acute myeloid leukemia dissected.
Strickland SA; Mohan SR; Savona MR
Curr Opin Hematol; 2016 Mar; 23(2):144-9. PubMed ID: 26825699
[TBL] [Abstract][Full Text] [Related]
9. Moving toward targeted therapies in acute myeloid leukemia.
Gao W; Estey E
Clin Adv Hematol Oncol; 2015 Nov; 13(11):748-54. PubMed ID: 27058701
[TBL] [Abstract][Full Text] [Related]
10. [Current therapy for acute myeloid leukemia and acute promyelocytic leukemia].
Miyawaki S
Rinsho Ketsueki; 2014 Jan; 55(1):31-41. PubMed ID: 24492035
[No Abstract] [Full Text] [Related]
11. Precision medicine in acute myeloid leukemia: Hope, hype or both?
Prasad V; Gale RP
Leuk Res; 2016 Sep; 48():73-7. PubMed ID: 27497757
[TBL] [Abstract][Full Text] [Related]
12. Differential prognosis impact of IDH2 mutations in cytogenetically normal acute myeloid leukemia.
Boissel N; Nibourel O; Renneville A; Huchette P; Dombret H; Preudhomme C
Blood; 2011 Mar; 117(13):3696-7. PubMed ID: 21454467
[No Abstract] [Full Text] [Related]
13. Individualizing Treatment for Newly Diagnosed Acute Myeloid Leukemia.
Reville PK; Kadia T
Curr Treat Options Oncol; 2020 Apr; 21(4):34. PubMed ID: 32318829
[TBL] [Abstract][Full Text] [Related]
14.
Sadigh S; Morrissette JJD; Bagg A
Leuk Lymphoma; 2019 Jun; 60(6):1601-1602. PubMed ID: 30632836
[No Abstract] [Full Text] [Related]
15. The road to precision oncology.
Biankin AV
Nat Genet; 2017 Feb; 49(3):320-321. PubMed ID: 28232728
[TBL] [Abstract][Full Text] [Related]
16. Molecular characterization of acute myeloid leukemia and its impact on treatment.
Frankfurt O; Licht JD; Tallman MS
Curr Opin Oncol; 2007 Nov; 19(6):635-49. PubMed ID: 17906465
[TBL] [Abstract][Full Text] [Related]
17. [Risk-adapted therapy in acute myeloid leukemia].
Fiegl M; Hiddemann W
Internist (Berl); 2012 Apr; 53(4):392, 394-9. PubMed ID: 22410942
[TBL] [Abstract][Full Text] [Related]
18. Genetic mutations in acute myeloid leukemia that influence clinical decisions.
Chung SS
Curr Opin Hematol; 2014 Mar; 21(2):87-94. PubMed ID: 24445361
[TBL] [Abstract][Full Text] [Related]
19. [New clinical evidence and drugs].
Kobayashi Y
Rinsho Ketsueki; 2013 Oct; 54(10):1660-70. PubMed ID: 24064815
[No Abstract] [Full Text] [Related]
20. Personalised vaccine against acute myeloid leukaemia.
Burki TK
Lancet Oncol; 2017 Jan; 18(1):e7. PubMed ID: 27989431
[No Abstract] [Full Text] [Related]
[Next] [New Search]
